Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Metastasis02:30

Metastasis

5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Science Journals.

Science (New York, N.Y.)Β·2026
Same author

Self-sustained heterogeneity drives PDAC.

Science signalingΒ·2026
Same author

In Science Journals.

Science (New York, N.Y.)Β·2026
Same author

In Science Journals.

Science (New York, N.Y.)Β·2026
Same author

An inflammation memento.

Science signalingΒ·2026
Same author

Fungi facilitate gut healing.

Science signalingΒ·2026
Same journal

ZNRF3 and RNF43 are active monomeric E3 ubiquitin ligases that self-associate.

Science signalingΒ·2026
Same journal

Allosteric ligands with distinct properties uncover tissue-specific physiological regulation mediated by free fatty acid receptor 2.

Science signalingΒ·2026
Same journal

Diacylglycerol kinase ΞΆ in B lymphocytes supports CD40-mediated immune synapse formation, mTORC1 signaling, and plasma cell fate.

Science signalingΒ·2026
Same journal

The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma.

Science signalingΒ·2026
Same journal

Fattening mother's milk with oxytocin.

Science signalingΒ·2026
Same journal

Virion display reveals MD-1 as an endogenous agonist for the orphan receptor GPRC5B.

Science signalingΒ·2026
See all related articles

Related Experiment Video

Updated: Sep 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Formate for tumor progression.

Annalisa M VanHook1

  • 1Science Signaling, AAAS, Washington, DC 20005, USA.

Science Signaling
|May 31, 2022
PubMed
Summary
This summary is machine-generated.

A specific bacterial metabolite was found to accelerate colorectal cancer progression. This discovery offers new insights into the gut microbiome

More Related Videos

Three-Dimensional 3D Tumor Spheroid Invasion Assay
12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

58.0K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

497

Related Experiment Videos

Last Updated: Sep 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Three-Dimensional 3D Tumor Spheroid Invasion Assay
12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

58.0K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

497

Area of Science:

  • Microbiology
  • Oncology
  • Gastroenterology

Background:

  • Colorectal cancer (CRC) is a significant global health concern.
  • The gut microbiome's role in cancer development is increasingly recognized.
  • Specific microbial products may influence tumor growth.

Purpose of the Study:

  • To investigate the impact of a particular bacterial metabolite on colorectal cancer progression.
  • To identify potential mechanisms by which microbial compounds affect CRC.

Main Methods:

  • Utilized in vitro cell culture models of colorectal cancer.
  • Employed in vivo mouse models to assess tumor growth.
  • Analyzed metabolite production by specific bacterial strains.

Main Results:

  • A identified bacterial metabolite significantly promoted colorectal cancer cell proliferation and migration.
  • The metabolite was shown to enhance tumor growth in preclinical models.
  • Specific signaling pathways were implicated in the metabolite's pro-tumorigenic effects.

Conclusions:

  • Bacterial metabolites can act as drivers of colorectal cancer progression.
  • Targeting specific microbial metabolites presents a potential therapeutic strategy for CRC.
  • Further research is warranted to explore the clinical relevance of these findings.